Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

587 Articles

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 27, 2017 at 10:55 AM EDT

Why AbbVie Won Big in Q3, and Can Keep Winning

AbbVie reported better-than-expected third-quarter before the markets opened on Friday due to strong sales of Humira and Imbruvica.

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 11, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa…

Jon C. Ogg | Oct 2, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one…

Lee Jackson | Oct 2, 2017 at 8:25 AM EDT

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

While it seems everything is fully priced, the good news for investors is that there is still a plethora of…

Chris Lange | Sep 28, 2017 at 12:45 PM EDT

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 25, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

1 … 22 23 24 25 26 … 40

AbbVie : ABBV

All AbbVie Articles

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

AbbVie and Amgen Reach Global Resolution of Humira

Major Pharma Short Interest Piles On

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

AbbVie : ABBV

All AbbVie Articles

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

AbbVie and Amgen Reach Global Resolution of Humira

Major Pharma Short Interest Piles On

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

Featured Reads

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On